Insulin Resistance and Insulin therapy

Insulin is a peptide hormone produced by the cells of the pancreatic islets of Langerhans that regulates blood glucose levels by aiding cellular glucose uptake, regulating carbohydrate, lipid, and protein metabolism, and encouraging cell division and proliferation through its mitogenic activities. Insulin resistance and its consequences are becoming more prominent as obesity and diabetes reach epidemic proportions in the developed world. Insulin resistance is described as a biological response that is diminished by a normal or elevated insulin level; traditionally, this refers to impaired sensitivity to insulin-mediated glucose disposal. Insulin resistance syndrome is a collection of anomalies and physical consequences that are more likely in people who are insulin resistant.

  1. Diagnosing diabetes
  2. Monitoring diabetes

    Related Conference of Insulin Resistance and Insulin therapy

    September 09-10, 2024

    33rd International Diabetes and Healthcare Conference

    Paris, France
    September 09-10, 2024

    7th Annual Meeting on Diabetes and Endocrinology

    Paris, France
    September 09-10, 2024

    4th European Endocrinology and Diabetes Congress

    Paris, France
    September 25-26, 2024

    5th World Summit on Diabetes Expo

    Rome, Italy
    October 14-15, 2024

    3rd International Summit on Hormonal Disorders

    Madrid, Spain
    November 22-23, 2024

    20th World Congress on Endocrinology & Diabetes

    Amsterdam, Netherlands

    Insulin Resistance and Insulin therapy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in